Response to letter regarding article, "randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with st-segment-elevation myocardial infarction"

Circulation: Cardiovascular Interventions

Volumn 6, Issue 2, 2013, Pages

  Alexopoulos, Dimitrios ^a   Xanthopoulou, Ioanna ^a   Gkizas, Vassilios ^a   Kassimis, George ^a   Theodoropoulos, Konstantinos ^a   Makris, George ^a   Koutsogiannis, Nikolaos ^a   Damelou, Anastasia ^a   Tsigkas, Grigorios ^a   Davlouros, Periklis ^a   Hahalis, George ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PRASUGREL; TICAGRELOR;

ANTICOAGULATION; CHRONIC DISEASE; HUMAN; LETTER; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY DELAY; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ADENOSINE; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES;

EID: 84879227743     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.000134     Document Type: Letter

References (3)

1. Alexopoulos D, Xanthopoulou I, Gkizas V, Kassimis G, Theodoropoulos KC, Makris G, Koutsogiannis N, Damelou A, Tsigkas G, Davlouros P, Hahalis G. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2012;5:797-804.
2. Funck-Jensen KL, Dalsgaard J, Grove EL, Hvas AM, Kristensen SD. Increased platelet aggregation and turnover in the acute phase of ST-elevation myocardial infarction. Platelets. Dec 5, 2012. doi: 10.3109/09537104.2012.738838.
3. Valgimigli M, Tebaldi M, Campo G, Gambetti S, Bristot L, Monti M, Parrinello G, Ferrari R; FABOLUS PRO Investigators. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. J Am Coll Cardiol Cardiovasc Interv. 2012;5:268-277.